Active and passive electrical properties of single bullfrog atrial cells.
Single cells from the bullfrog (Rana catesbeiana) atrium have been prepared by using a modification of the enzymatic dispersion procedure described by Bagby et al. (1971. Nature [Long.]. 234:351--352) and Fay and Delise (1973. Proc. Natl. Acad. Sci. U.S.A. 70:641--645). Visualization of relaxed cells via phase-contrast or Nomarski optics (magnification, 400--600) indicates that cells range between 150 and 350 micrometers in length and 4 and 7 micrometers in diameter. The mean sarcomere length in relaxed, quiescent atrial cells in 2.05 micrometer. Conventional electrophysiological measurements have been made. In normal Ringer's solution (2.5 mM K+, 2.5 mM Ca++) acceptable cells have stable resting potentials of about -88 mV, and large (125 mV) long-duration (approximately 720 ms) action potentials can be elicited. The Vm vs. log[K+]0 relation obtained from isolated cells is similar to that of the intact atrium. The depolarizing phase of the action potential of isolated atrial myocytes exhibits two pharmacologically separable components: tetrodotoxin (10(-6) g/ml) markedly suppresses the initial regenerative depolarization, whereas verapamil (3 x 10(-6) M) inhibits the secondary depolarization and reduce the plateau height. A bridge circuit was used to estimate the input resistance (220 +/- 7 M omega) and time constant 20 +/- 7 ms) of these cells. Two-microelectrode experiments have revealed small differences in the electrotonic potentials recorded simultaneously at two different sites within a single cell. The equations for a linear, short cable were used to calculate the electrical constants of relaxed, single atrial cells: lambda = 921.3 +/- 29.5 micrometers; Ri = 118.1 +/- 24.5 omega cm; Rm = 7.9 +/- 1.2 x 10(3) omega cm2; Cm = 2.2 +/- 0.3 mu Fcm-2. These results and the atrial cell morphology suggest that this preparation may be particularly suitable for voltage-clamp studies.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D016275:Atrial Function; D006321:Heart / Q000502:physiology*; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D009206:Myocardium / Q000166:cytology*; D011892:Rana catesbeiana; D013779:Tetrodotoxin / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D013779:Tetrodotoxin; D014700:Verapamil